Neuromod Devices Stock

Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.

Sign up today and learn more about Neuromod Devices Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Neuromod Devices Stock

Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.

Funding History

June 2011$200K
September 2015$6.8M
September 2019$8.0M
October 2020$10.5M
April 2023$15.0M
April 2023$15.0M

Management

CHIEF FINANCIAL OFFICER

Derek Madden

Chief Commercial Officer

Florian Elsaesser

CHIEF MEDICAL OFFICER

Brendan Conlon

President, Global Commercial Operations & CEO Neuromod USA

Eric Timm

Chief Scientific Officer

Hubert Lim

Board of Directors

Manus Rogan

Chief Operations Officer

Rosemarie Tully

Board Member

Alessio Beverina

Founder & CEO

Ross O'Neill

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo